The role of multiple sclerosis therapies on the dynamic of human gut microbiota

Gut microbiota, the total microorganisms in our gastrointestinal tract, might have an implication in multiple sclerosis (MS), a demyelinating neurological disease. Our study included 50 MS patients and 21 healthy controls (HC). Twenty patients received a disease modifying therapy (DMT), interferon beta1a or teriflunomide, 19 DMT combined with homeopathy and 11 patients accepted only homeopathy. We collected in total 142 gut samples, two for each individual: at the study enrolment and eight weeks after treatment.

Source: Journal of Neuroimmunology - April 7, 2023 Category: Allergy & Immunology Authors: Vitalie Vacaras, Dafin F. Muresanu, Anca-Dana Buzoianu, Cristina Nistor, Stefan Cristian Vesa, Andreea Cristina Paraschiv, Daniela Botos-Vacaras, Cristiana Vacaras, George Vithoulkas Source Type: research